284 related articles for article (PubMed ID: 30121369)
1. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
Hechtman JF; Abou-Alfa GK; Stadler ZK; Mandelker DL; Roehrl MHA; Zehir A; Vakiani E; Middha S; Klimstra DS; Shia J
Hum Pathol; 2019 Jan; 83():1-6. PubMed ID: 30121369
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
[TBL] [Abstract][Full Text] [Related]
3. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
Cho SJ; Ferrell LD; Gill RM
Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
[TBL] [Abstract][Full Text] [Related]
4. [Hepatocellular carcinoma in an inflammatory adenoma with β-catenin mutation in a patient with hepatocellular adenomatosis due to germline mutation in HNF1α].
Ridder DA; Duret D; Wörns MA; Schotten S; Heinrich S; Kloth M; Springer E; Roth W; Straub BK
Z Gastroenterol; 2019 Jan; 57(1):46-51. PubMed ID: 30641602
[TBL] [Abstract][Full Text] [Related]
5. Natural history of liver adenomatosis: A long-term observational study.
Barbier L; Nault JC; Dujardin F; Scotto B; Besson M; de Muret A; Bourlier P; Zucman-Rossi J; Salamé E; Bacq Y
J Hepatol; 2019 Dec; 71(6):1184-1192. PubMed ID: 31419515
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
[TBL] [Abstract][Full Text] [Related]
7. Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation.
Willson JS; Godwin TD; Wiggins GA; Guilford PJ; McCall JL
J Hepatol; 2013 Oct; 59(4):904-7. PubMed ID: 23707370
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of hepatic adenomas.
Micchelli ST; Vivekanandan P; Boitnott JK; Pawlik TM; Choti MA; Torbenson M
Mod Pathol; 2008 Apr; 21(4):491-7. PubMed ID: 18246041
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis.
Calderaro J; Nault JC; Balabaud C; Couchy G; Saint-Paul MC; Azoulay D; Mehdaoui D; Luciani A; Zafrani ES; Bioulac-Sage P; Zucman-Rossi J
Mod Pathol; 2016 Jan; 29(1):43-50. PubMed ID: 26516697
[TBL] [Abstract][Full Text] [Related]
11. Molecular classification of hepatocellular adenoma in clinical practice.
Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
[TBL] [Abstract][Full Text] [Related]
12. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
13. Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.
Pilati C; Letouzé E; Nault JC; Imbeaud S; Boulai A; Calderaro J; Poussin K; Franconi A; Couchy G; Morcrette G; Mallet M; Taouji S; Balabaud C; Terris B; Canal F; Paradis V; Scoazec JY; de Muret A; Guettier C; Bioulac-Sage P; Chevet E; Calvo F; Zucman-Rossi J
Cancer Cell; 2014 Apr; 25(4):428-41. PubMed ID: 24735922
[TBL] [Abstract][Full Text] [Related]
14. Morphologic and Molecular Findings in Myxoid Hepatic Adenomas.
Rowan DJ; Yasir S; Chen ZE; Mounajjed T; Erdogan Damgard S; Cummins L; Zhang L; Whitcomb E; Falck V; Simon SM; Singhi AD; Torbenson MS
Am J Surg Pathol; 2021 Aug; 45(8):1098-1107. PubMed ID: 34232602
[TBL] [Abstract][Full Text] [Related]
15. Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature.
Fu J; Wang T; Zhai X; Xiao X
Endocrine; 2020 Mar; 67(3):544-551. PubMed ID: 31754975
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage.
Jeannot E; Mellottee L; Bioulac-Sage P; Balabaud C; Scoazec JY; Tran Van Nhieu J; Bacq Y; Michalak S; Buob D; ; Laurent-Puig P; Rusyn I; Zucman-Rossi J
Diabetes; 2010 Jul; 59(7):1836-44. PubMed ID: 20393147
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers.
Haring MPD; Vriesendorp TM; Klein Wassink-Ruiter JS; de Haas RJ; Gouw ASH; de Meijer VE
Liver Int; 2019 Nov; 39(11):2042-2045. PubMed ID: 31483937
[TBL] [Abstract][Full Text] [Related]
18. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.
Haddouche A; Bellanne-Chantelot C; Rod A; Fournier L; Chiche L; Gautier JF; Timsit J; Laboureau S; Chaillous L; Valero R; Larger E; Jeandidier N; Wilhelm JM; Popelier M; Guillausseau PJ; Thivolet C; Lecomte P; Benhamou PY; Reznik Y
J Diabetes; 2020 Jan; 12(1):48-57. PubMed ID: 31166087
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular neoplasms with loss of liver fatty acid binding protein: Clinicopathologic features and molecular profiling.
Joseph NM; Blank A; Shain AH; Gill RM; Umetsu SE; Shafizadeh N; Torbenson MS; Kakar S
Hum Pathol; 2022 Apr; 122():60-71. PubMed ID: 35104461
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Adenomas: Morphology and Genomics.
Bioulac-Sage P; Sempoux C; Balabaud C
Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
